April 17, 2018 / 12:10 PM / in 4 months

BRIEF-FDA Provides Full Approval To Praxbind, Specific Reversal Agent For Pradaxa

April 17 (Reuters) - FDA-

* FDA PROVIDES FULL APPROVAL TO PRAXBIND, SPECIFIC REVERSAL AGENT FOR PRADAXA

* BOEHRINGER INGELHEIM SAYS U.S. FDA PROVIDED FULL APPROVAL FOR PRAXBIND , THE SPECIFIC REVERSAL AGENT FOR PRADAXA Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below